U.S. Stock Perpetuals Raise Regulatory Questions as Lawsuit and Approvals Remain Unconfirmed
U.S. stock perpetuals sit at a regulatory crossroads: existing law divides oversight of securities and derivatives, but it doesn’t clearly settle how expiry-free contracts fit. Reports of a lawsuit, approvals and court actions remain unconfirmed—while leverage risks are very real.
Read Full Article